|
|
||||||||





* Immunology and
Molecular Biology Disciplinary Programs, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile;
Department of Microbiology and Immunology, University of Leicester, Leicester, United Kingdom; and
Medical Research Council Immunochemistry Unit, Department of Biochemistry, University of Oxford, Oxford, United Kingdom
The high resistance of Trypanosoma cruzi trypomastigotes, the causal agent of Chagas disease, to complement involves several parasite strategies. In these in vitro studies, we show that T. cruzi calreticulin (TcCRT) and two subfragments thereof (TcCRT S and TcCRT R domains) bind specifically to recognition subcomponents of the classical and lectin activation pathways (i.e., to collagenous tails of C1q and to mannan-binding lectin) of the human complement system. As a consequence of this binding, specific functional inhibition of the classical pathway and impaired mannan-binding lectin to mannose were observed. By flow cytometry, TcCRT was detected on the surface of viable trypomastigotes and, by confocal microscopy, colocalization of human C1q with surface TcCRT of infective trypomastigotes was visualized. Taken together, these findings imply that TcCRT may be a critical factor contributing to the ability of trypomastigotes to interfere at the earliest stages of complement activation.
This article has been cited by other articles:
![]() |
A. Watanabe, S. Miyazawa, M. Kitami, H. Tabunoki, K. Ueda, and R. Sato Characterization of a Novel C-Type Lectin, Bombyx mori Multibinding Protein, from the B. mori Hemolymph: Mechanism of Wide-Range Microorganism Recognition and Role in Immunity J. Immunol., October 1, 2006; 177(7): 4594 - 4604. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |